Standout Papers

De novo design of picomolar SARS-CoV-2 miniprotein inhibitors 2020 2026 2022 2024436
  1. De novo design of picomolar SARS-CoV-2 miniprotein inhibitors (2020)
    Longxing Cao, Inna Goreshnik et al. Science

Citation Impact

Citing Papers

Fast and versatile sequence-independent protein docking for nanomaterials design using RPXDock
2023 StandoutNobel
Characterizing and explaining the impact of disease-associated mutations in proteins without known structures or structural homologs
2022 StandoutNobel
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
2021 StandoutScienceNobel
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
2022 StandoutNobel
Exploiting conformational dynamics to modulate the function of designed proteins
2023 StandoutNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
A fragment-based protein interface design algorithm for symmetric assemblies
2021
Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
2023 StandoutNobel
Sculpting conducting nanopore size and shape through de novo protein design
2024 StandoutScienceNobel
Intranasal gene therapy to prevent infection by SARS-CoV-2 variants
2021
Elucidating Design Principles for Engineering Cell‐Derived Vesicles to Inhibit SARS‐CoV‐2 Infection
2022
Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists
2024 StandoutScienceNobel
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Recent advances in de novo protein design: Principles, methods, and applications
2021
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
The promise of mRNA vaccines: a biotech and industrial perspective
2020
Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2
2021
De Novo Design of a Highly Stable Ovoid TIM Barrel: Unlocking Pocket Shape towards Functional Design
2022
Computationally designed sensors detect endogenous Ras activity and signaling effectors at subcellular resolution
2024 StandoutNobel
Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro
2020
Sampling of structure and sequence space of small protein folds
2022 StandoutNobel
SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis
2021
Machine learning for functional protein design
2024
Accurate de novo design of heterochiral protein–protein interactions
2024 StandoutNobel
Enhancing extracellular vesicle cargo loading and functional delivery by engineering protein-lipid interactions
2024 StandoutNobel
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
COVID-19-neutralizing antibodies predict disease severity and survival
2020
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Multistate and functional protein design using RoseTTAFold sequence space diffusion
2024 StandoutNobel
Development of vaccines and antivirals for combating viral pandemics
2020 StandoutNobel
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
2021 StandoutNobel
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Targeted N-glycan deletion at the receptor-binding site retains HIV Env NFL trimer integrity and accelerates the elicited antibody response
2017
Transient water wires mediate selective proton transport in designed channel proteins
2023
Opportunities and challenges in design and optimization of protein function
2024
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
2021
Recent advances in mRNA vaccine technology
2020 StandoutNobel
A Brief History of De Novo Protein Design: Minimal, Rational, and Computational
2021
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
2022 StandoutNobel
An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
2020
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
2021
Tick immunity using mRNA, DNA and protein-based Salp14 delivery strategies
2021 StandoutNobel
Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling
2021
Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses
2020
Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors
2020 StandoutNobel
The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses
2020
MutDock: A computational docking approach for fixed-backbone protein scaffold design
2022
SARS-CoV-2 variants, spike mutations and immune escape
2021 Standout
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
2020
Design of amyloidogenic peptide traps
2024 StandoutNobel
De novo design of buttressed loops for sculpting protein functions
2024 StandoutNobel
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent
2021
End-to-end design of wearable sensors
2022 Standout
Computational design of novel protein–protein interactions – An overview on methodological approaches and applications
2022
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
SARS-CoV-2 vaccines in development
2020 StandoutNature
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
2021
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Enhanced SARS-CoV-2 neutralization by dimeric IgA
2020 StandoutNobel
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
De novo designed protein inhibitors of amyloid aggregation and seeding
2022
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation
2022 StandoutNobel
mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent
2021 StandoutNobel
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
Rapid and Sensitive Detection of Antigen from SARS-CoV-2 Variants of Concern by a Multivalent Minibinder-Functionalized Nanomechanical Sensor
2022 StandoutNobel
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
De Novo Protein Design Using the Blueprint Builder in Rosetta
2020
De novo protein fold design through sequence-independent fragment assembly simulations
2023
Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants
2021
De novo design of small beta barrel proteins
2023 StandoutNobel
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
Reshaping de Novo Protein Switches into Bioresponsive Materials for Biomarker, Toxin, and Viral Detection
2022 StandoutNobel
De novo design of protein homodimers containing tunable symmetric protein pockets
2022 StandoutNobel
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
Top-down design of protein architectures with reinforcement learning
2023 StandoutScienceNobel
The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies
2020

Works of Rita E. Chen being referenced

Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2
2020
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
2020 StandoutScienceNobel
Growth, detection, quantification, and inactivation of SARS-CoV-2
2020
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice
2020
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
2021
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
2021
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
2021
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
2020
Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody
2015
Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice
2019
Landscape Analysis of Escape Variants Identifies SARS-CoV-2 Spike Mutations that Attenuate Monoclonal and Serum Antibody Neutralization
2020
Rankless by CCL
2026